SS&C Technologies CapEx decreased by 42.9% to $6.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 52.8%, from $12.70M to $6.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 12.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.50M | $13.40M | $20.30M | $10.80M | $11.80M | $30.70M | $10.10M | $10.50M | $13.70M | $16.50M | $15.90M | $5.80M | $10.00M | $25.90M | $19.70M | $12.70M | $22.90M | $34.70M | $10.50M | $6.00M |
| QoQ Change | — | +57.6% | +51.5% | -46.8% | +9.3% | +160.2% | -67.1% | +4.0% | +30.5% | +20.4% | -3.6% | -63.5% | +72.4% | +159.0% | -23.9% | -35.5% | +80.3% | +51.5% | -69.7% | -42.9% |
| YoY Change | — | — | — | — | +38.8% | +129.1% | -50.2% | -2.8% | +16.1% | -46.3% | +57.4% | -44.8% | -27.0% | +57.0% | +23.9% | +119.0% | +129.0% | +34.0% | -46.7% | -52.8% |